NLRP3 and infection: Conversely, it is also possible that the reduction in IL1β protein maturation in PAMs treated with MCC950 prior to infection reduces the overall immunological response to infection in these cells and creates a more favorable environment for PRRSV replication, than in mock-treated PAMs, which should have fully functional NLRP3 inflammasome activity.